C12Q 2539/00
Reactions characterised by analysis of gene expression or genome comparison
C12Q2539/00 (Reactions characterised by analysis of gene expression or genome comparison) appears on 36 US grants and 87 published applications in this corpus.
Search patents in C12Q- Granted patents
- 36
- Published applications
- 87
- Assignees
- 47
- Inventors
- 180
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 2 | 1 |
| 2003 | 0 | 2 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 1 |
| 2014 | 0 | 5 |
| 2015 | 1 | 4 |
| 2016 | 0 | 0 |
| 2017 | 1 | 6 |
| 2018 | 2 | 11 |
| 2019 | 2 | 10 |
| 2020 | 1 | 4 |
| 2021 | 6 | 6 |
| 2022 | 12 | 6 |
| 2023 | 1 | 8 |
| 2024 | 4 | 7 |
| 2025 | 3 | 7 |
| 2026 | 1 | 8 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Methods and compositions for determining ploidy25 Aug 2026US 12,716,090 B2Natera, Inc.
- Detecting mutations and ploidy in chromosomal segments2 Dec 2025US 12,486,542 B2Natera, Inc.
- Methods relating to lung cancer17 Jun 2025US 12,329,771 B2Trustees of Boston University
- Detecting mutations and ploidy in chromosomal segments21 Jan 2025US 12,203,142 B2Natera, Inc.
- Type I interferon signatures and methods of use11 Jun 2024US 12,009,079 B2Janssen Biotech, Inc.
- Detecting mutations and ploidy in chromosomal segments3 Sep 2026US 2026/0258505 A1Natera, Inc.
- Detecting mutations and ploidy in chromosomal segments30 Jul 2026US 2026/0218314 A1Natera, Inc.
- Detecting mutations and ploidy in chromosomal segments18 Jun 2026US 2026/0168033 A1Natera, Inc.
- Detecting mutations and ploidy in chromosomal segments11 Jun 2026US 2026/0159900 A1Natera, Inc.
- Detecting mutations and ploidy in chromosomal segments4 Jun 2026US 2026/0152806 A1Natera, Inc.
Most cited
By later US patents
- Spatial mapping of nucleic acid sequence information116US 10,913,975 B2Illumina, Inc. · 2021
- Detecting mutations and ploidy in chromosomal segments99US 10,179,937 B2Natera, Inc. · 2019
- Detecting mutations and ploidy in chromosomal segments45US 11,319,596 B2Natera, Inc. · 2022
- Detecting mutations and ploidy in chromosomal segments45US 11,371,100 B2Natera, Inc. · 2022
- Selective reduction of allelic variants27US 9,006,198 B2Isis Pharmaceuticals, Inc. · 2015